content top

Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema Part II: Initial Intervention

Mahmoud M. Soliman, MD, Tamer A. Macky, MD, FRCSED, Nermeen A. Fawzi, M.Sc., Noha Khater, MD, FRCSED, MRCOphth. Purpose: To evaluate the clinical outcome and safety of intravitreal injection of triamcinolone acetonide (TA) as an initial therapy for diffuse diabetic macular edema. Setting: Department of Ophthalmology, Cairo University Hospitals, Cairo, Egypt. Methods: Ten eyes of eight patients with diffuse clinically significant macular...

Read More

Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema: Part I: Refractory Cases: Two Years Experience

Mahmoud M. Soliman, MD, Tamer A. Macky, MD, FRCSED, Nermeen A. Fawzi, M.Sc., Noha Khater, MD, FRCSED, MRCOphth. Purpose: To report our two-years experience with the safety and efficacy of intravitreal triamcinolone acetonide (TA) in treating diffuse diabetic macular edema refractory to laser. Setting: Department of Ophthalmology, Cairo University Hospitals, Cairo, Egypt. Methods: Fourteen eyes of 10 patients with clinically significant...

Read More

Intravitreal Triamcinolone Acetonide During Phacoemulsification for Patients with Diabetic Macular Edema and Dense Cataracts

Noha Khater, MD, FRCSED, MRCOphth., Mahmoud M. Soliman, MD, Nermeen A. Fawzi, M. Sc., Tamer A. Macky, MD, FRCSED Purpose: To evaluate the efficacy of intravitreal triamcinolone acetonide (TA) during phacoemulsification in preventing deterioration of macular edema in diabetic patients with clinically significant cataract. Setting: Department of Ophthalmology, Cairo University Hospitals, Cairo, Egypt Methods: Twenty four eyes of eighteen...

Read More
content top